Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma: subgroup analyses from CheckMate 040

被引：0

作者：

Sangro, Bruno ^{[1
,2
]}

He, Aiwu Ruth ^{[3
]}

Yau, Thomas ^{[4
]}

Hsu, Chiun ^{[5
]}

Kang, Yoon-Koo ^{[6
,7
]}

Kim, Tae-You ^{[8
]}

Santoro, Armando ^{[9
]}

Melero, Ignacio ^{[10
]}

Kudo, Masatoshi ^{[11
]}

Ho, Ming-Mo ^{[12
]}

Matilla, Ana ^{[13
,14
]}

Tovoli, Francesco ^{[15
]}

Knox, Jennifer ^{[16
]}

El-Rayes, Bassel ^{[17
]}

Acosta, Mirelis Rivera ^{[18
]}

Neely, Jaclyn ^{[19
]}

Shen, Yun ^{[19
]}

Tschaika, Marina ^{[19
]}

El-Khoureiry, Anthony ^{[20
]}

机构：

[1] Clin Univ Navarra, Pamplona, Spain

[2] CIBEREHD, Pamplona, Spain

[3] Georgetown Univ Hosp, Washington, DC 20007 USA

[4] Univ Hong Kong, Hong Kong, Peoples R China

[5] Natl Taiwan Univ Hosp, Taipei, Taiwan

[6] Asan Med Ctr, Seoul, South Korea

[7] Univ Ulsan, Seoul, South Korea

[8] Seoul Natl Univ, Seoul, South Korea

[9] Ist Clin Humanitas, Rozzano, Italy

[10] Univ Navarra, Pamplona, Spain

[11] Kindai Univ, Fac Med, Osaka, Japan

[12] Chang Gung Mem Hosp, Taipei, Taiwan

[13] Hosp Gen Univ Gregorio Maranon, Serv Digest, Madrid, Spain

[14] CIBEREHD, Madrid, Spain

[15] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy

[16] Princess Margaret Canc Ctr, Toronto, ON, Canada

[17] Emory Univ, Winship Ctr, Atlanta, GA 30322 USA

[18] Fdn Invest, San Juan, PR USA

[19] Bristol Myers Squibb, Princeton, NJ USA

[20] USC, Norris Comprehens Canc Ctr, Los Angeles, CA USA

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LBO11

引用

页码：S121 / S122

页数：2

共 50 条

[1] Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Subgroup analyses from CheckMate 040
He, Aiwu Ruth
Yau, Thomas
Hsu, Chiun
Kang, Yoon-Koo
Kim, Tae-You
Santoro, Armando
Sangro, Bruno
Melero, Ignacio
Kudo, Masatoshi
Hou, Ming-Mo
Matilla, Ana
Tovoli, Francesco
Knox, Jennifer J.
El-Rayes, Bassel F.
Acosta-Rivera, Mirelis
Neely, Jaclyn
Shen, Yun
Tschaika, Marina
El-Khoueiry, Anthony B.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[2] Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
Sangro, Bruno
Yau, Thomas
El-Khoueiry, Anthony B.
Kudo, Masatoshi
Shen, Yun
Tschaika, Marina
Roy, Amit
Feng, Yan
Gao, Ling
Aras, Urvi
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (08): : 1445 - 1457
[3] CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
Sangro, Bruno
Hsu, Chiun
Kang, Yoon-Koo
Kim, Tae-You
El-Khoueiry, Anthony
Santoro, Armando
Melero, Ignacio
Kudo, Masatoshi
Hou, Ming-Mo
Pena, Ana Matilla
Tovoli, Francesco
Knox, Jennifer J.
He, Aiwu Ruth
El-Rayes, Bassel
Acosta, Mirelis Rivera
Lim, Ho-Yeong
Neely, Jaclyn
Zhao, Huanyu
Anderson, Jeffrey
Yau, Thomas
HEPATOLOGY, 2019, 70 : 131A - 132A
[4] Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
Yau, Thomas
Kang, Yoon-Koo
Kim, Tae-You
El-Khoueiry, Anthony B.
Santoro, Armando
Sangro, Bruno
Melero, Ignacio
Kudo, Masatoshi
Hou, Ming-Mo
Matilla, Ana
Tovoli, Francesco
Knox, Jennifer J.
He, Aiwu Ruth
El-Rayes, Bassel F.
Acosta-Rivera, Mirelis
Neely, Jaclyn
Shen, Yun
Baccan, Carlos
Dela Cruz, Christine Marie
Hsu, Chiun
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[5] Nivolumab (NIVO) plus ipilimumab (IPI) plus cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040
Yau, Thomas
Zagonel, Vittorina
Santoro, Armando
Acosta-Rivera, Mirelis
Choo, Su Pin
Matilla, Ana
He, Aiwu Ruth
Gracian, Antonio Cubillo
El-Khoueiry, Anthony B.
Sangro, Bruno
Eldawy, Tarek
Bruix, Jordi
Frassineti, Giovanni
Vaccaro, Gina M.
Tschaika, Marina
Scheffold, Christian
Shen, Yun
Neely, Jaclyn
Piscaglia, Fabio
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[6] Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
Melero, I.
Yau, T.
Kang, Y. -K.
Kim, T. -Y.
Santoro, A.
Sangro, B.
Kudo, M.
Hou, M. -M.
Matilla, A.
Tovoli, F.
Knox, J.
He, A. R.
El-Rayes, B.
Acosta-Rivera, M.
Lim, H. Y.
Soleymani, S.
Yao, J.
Neely, J.
Tschaika, M.
Hsu, C.
El-Khoueiry, A. B.
ANNALS OF ONCOLOGY, 2024, 35 (06) : 537 - 548
[7] Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients with advanced hepatocellular carcinoma (aHCC): 5-year results from CheckMate 040
Melero, I.
Yau, T.
Kang, Y.
Kim, T.
Santoro, A.
Sangro, B.
Kudo, M.
Hou, M.
Matilla, A.
Tovoli, F.
Knox, J.
He, A.
El-Rayes, B.
Acosta-Rivera, M.
Lim, H.
Soleymani, S.
Yao, J.
Neely, J.
Tschaika, M.
Hsu, C.
El-Khoueiry, A.
ANNALS OF ONCOLOGY, 2022, 33 : S361 - S361
[8] Efficacy and safety of nivolumab plus ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study
Yau, T.
Hsu, C.
Kang, Y.
Kim, T.
Hou, M.
Lim, H.
Chao, Y.
Kim, Y.
Ikeda, M.
Choo, S.
Neely, J.
Shen, Y.
Tschaika, M.
Kudo, M.
ANNALS OF ONCOLOGY, 2020, 31 : S233 - S233
[9] Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040.
El-Khoueiry, Anthony B.
Yau, Thomas
Kang, Yoon-Koo
Kim, Tae-You
Santoro, Armando
Sangro, Bruno
Melero, Ignacio
Kudo, Masatoshi
Hou Ming-Mo
Matilla, Ana
Tovoli, Francesco
Knox, Jennifer J.
He, Aiwu Ruth
El-Rayes, Bassel F.
Acosta-Rivera, Mirelis
Lim, Ho Yeong
Memaj, Arteid
Sama, Ashwin Reddy
Hsu, Chiun
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[10] Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
Yau, Thomas
Zagonel, Vittorina
Santoro, Armando
Acosta-Rivera, Mirelis
Choo, Su Pin
Matilla, Ana
He, Aiwu Ruth
Cubillo Gracian, Antonio
El-Khoueiry, Anthony B.
Sangro, Bruno
Eldawy, Tarek E.
Bruix, Jordi
Frassineti, Giovanni Luca
Vaccaro, Gina M.
Tschaika, Marina
Scheffold, Christian
Koopmans, Petra
Neely, Jaclyn
Piscaglia, Fabio
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1747 - +

← 1 2 3 4 5 →